• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本非胰岛素依赖型糖尿病(NIDDM)发病的危险因素。

Risk factors for the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japan.

作者信息

Kadowaki T, Yoshinaga H

机构信息

Third Department of Internal Medicine, University of Tokyo, Japan.

出版信息

Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S123-7. doi: 10.1016/0168-8227(94)90238-0.

DOI:10.1016/0168-8227(94)90238-0
PMID:7859593
Abstract

Follow-up studies of subjects with impaired glucose tolerance in Japan have shown that a higher level of blood glucose is a major predictor of the subsequent development of non-insulin-dependent diabetes mellitus (NIDDM). In addition, subjects with a lower insulin response to glucose show a higher risk for the development of NIDDM. In fact, most of the subjects who later develop diabetes show a lower insulin response to glucose at the initial examination. Moreover, obesity is generally associated with a higher risk of developing NIDDM. We conclude that low insulin secretion forms an important basis and obesity plays a precipitating role among low-insulin responders in the pathogenesis of the majority of NIDDM patients in Japan.

摘要

日本针对糖耐量受损人群的后续研究表明,较高的血糖水平是随后发生非胰岛素依赖型糖尿病(NIDDM)的主要预测指标。此外,对葡萄糖的胰岛素反应较低的人群患NIDDM的风险更高。事实上,大多数后来患糖尿病的人在初次检查时对葡萄糖的胰岛素反应较低。此外,肥胖通常与患NIDDM的较高风险相关。我们得出结论,在日本大多数NIDDM患者的发病机制中,胰岛素分泌不足是一个重要基础,而肥胖在胰岛素反应低的人群中起促发作用。

相似文献

1
Risk factors for the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japan.日本非胰岛素依赖型糖尿病(NIDDM)发病的危险因素。
Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S123-7. doi: 10.1016/0168-8227(94)90238-0.
2
On the pathogenesis of type II diabetes with special reference to diminished insulin response and obesity: a 5-12 year follow-up study of subjects with borderline glucose tolerance.关于II型糖尿病的发病机制,特别涉及胰岛素反应减弱和肥胖:对糖耐量临界受试者的5至12年随访研究
Tohoku J Exp Med. 1983 Dec;141 Suppl:141-6. doi: 10.1620/tjem.141.suppl_141.
3
Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.南非印度人中的短暂性糖耐量受损不会增加进展为非胰岛素依赖型糖尿病的风险。
Diabetes Care. 1997 Jul;20(7):1101-7. doi: 10.2337/diacare.20.7.1101.
4
Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.在已确诊的非胰岛素依赖型糖尿病中,口服葡萄糖负荷后的胰岛素反应持续降低:早期胰岛素反应降低作为非胰岛素依赖型糖尿病预测指标的实用性。
Diabet Med. 1996 Sep;13(9 Suppl 6):S109-19.
5
Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.在非胰岛素依赖型糖尿病发病机制中,胰岛素分泌受损比内脏脂肪增多出现得更早。对最初无糖尿病的日裔美国男性进行的5年随访。
Diabetes Care. 1995 Jun;18(6):747-53. doi: 10.2337/diacare.18.6.747.
6
Glucose, insulin concentrations and obesity in childhood and adolescence as predictors of NIDDM.
Diabetologia. 1994 Jun;37(6):617-23. doi: 10.1007/BF00403382.
7
Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men.身体状况不佳、早期胰岛素反应受损但后期出现高胰岛素血症,作为瑞典中年男性非胰岛素依赖型糖尿病的预测指标。
Diabetologia. 1996 May;39(5):573-9. doi: 10.1007/BF00403304.
8
The natural history of impaired glucose tolerance in the Pima Indians.皮马印第安人糖耐量受损的自然病史。
N Engl J Med. 1988 Dec 8;319(23):1500-6. doi: 10.1056/NEJM198812083192302.
9
The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance.生育次数对非胰岛素依赖型糖尿病后期发展或糖耐量受损的影响。
N Engl J Med. 1989 Nov 2;321(18):1214-9. doi: 10.1056/NEJM198911023211802.
10
Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus.
Eur J Clin Invest. 1998 Sep;28 Suppl 2:8-13. doi: 10.1046/j.1365-2362.1998.0280s2008.x.

引用本文的文献

1
Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension period.在接受胰岛素单药治疗的日本 2 型糖尿病患者中添加伊美格鲁肽的疗效和安全性(TIMES 3):一项随机、双盲、安慰剂对照的 3 期临床试验,有 36 周的开放标签扩展期。
Diabetes Obes Metab. 2022 May;24(5):838-848. doi: 10.1111/dom.14642. Epub 2022 Feb 8.
2
Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study.西他列汀改善日本 2 型糖尿病患者口服糖耐量试验中受损的急性胰岛素反应:一项小规模真实世界研究。
Diabetes Ther. 2014 Jun;5(1):285-97. doi: 10.1007/s13300-014-0071-1. Epub 2014 Jun 3.
3
The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.2型糖尿病餐后靶向治疗可降低胰岛素原/胰岛素(PI/I)比值:一项小规模临床研究。
BMC Res Notes. 2013 Nov 11;6:453. doi: 10.1186/1756-0500-6-453.
4
20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.20/(空腹 C 肽×空腹血糖)是 2 型糖尿病患者胰岛素抵抗的一个简单而有效的指标:初步报告。
Cardiovasc Diabetol. 2013 Jan 22;12:21. doi: 10.1186/1475-2840-12-21.